SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen How who wrote (1040)7/2/1998 1:09:00 AM
From: Stephen How  Read Replies (1) of 1432
 
Discussion of albumin in Biotime patents.

I noticed that Biotime patent 5,747,071 "Plasma-like substance" ( patents.ibm.com ) describes the use of albumin in the invention. The invention covers a mixture of one or two oncontic agents (from hi or low weight HES, Dextran, Albumin), electrolytes, buffer, and sugar:

"It is particularly advantageous to use albumin in the solutions according to the invention. As a mammalian blood protein, albumin has several important physiological functions which are more completely preserved when the solution according to the invention comprise albumin. As a blood protein, ablumin is an important ion-binding protein which binds to essential divalent cations, particularly calcium ion. Thus, by using albumin as an oncotic agent in the solutions according to the invention, particularly the two oncotic agent solutions, the capacity of the subject to maintain normal circulating and tissue calcium ion concentrations is enhanced over solutions such as HetaStarch, Pentastarch, Rheomax and other similar commercial preparations. Approximately 50% of the Calcium ion in the mammalian circulation is bound to protein and albumin comprise approximately 60% of the circulating blood proteins."

These seem to be some reasons why albumin continues to be widely used. It also shows that the inventors did not assume that the adding Ca++ to hetastarch was going to solve all the coagulation problems.

I had previously posted an excerpt on hypocalcemia from a website on massive blood volume replacement ( trauma.org ):

Hypocalcaemia

Each unit of blood contains approximately 3g citrate, which binds ionized calcium. The healthy adult liver will metabolise 3g citrate every 5 minutes. Transfusion at rates higher than one unit every five minutes or impaired liver function may thus lead to citrate toxicity and hypocalcaemia. Hypocalcaemia does not have a clinically apparent effect on coagulation, but patients may exhibit transient tetany and hypotension. Calcium should only be given if there is biochemical, clinical or electrocardiographic evidence of hypocalcaemia.


Steve

btim.dyn.ml.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext